CClinicalTrials.gg
Not yet recruitingNCT07461753Q_ITAUpdated Mar 10, 2026

Development, Validation, and Assessment of the Diagnostic Accuracy of a Questionnaire for Periodontitis Screening

An observational study in Periodontal Diseases and Periodontitis, sponsored by Azienda Unità Sanitaria Locale (A.U.S.L.) Ferrara, Italy. Not yet recruiting. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-03-10.

Sponsored by Azienda Unità Sanitaria Locale (A.U.S.L.) Ferrara, Italy · Observational

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
495
Ages
18 Years and older
Sex
All
01

Study summary

The present study aims at validating the Italian version of one of the most widely used epidemiological questionnaires for periodontitis screening: the CDC/AAP questionnaire [hereafter referred to as the CDC/AAP_ITA questionnaire].

The study also aims to develop a modified version of the CDC/AAP questionnaire, enriched with additional questions, and to evaluate its diagnostic accuracy [hereafter referred to as the QSIdP questionnaire].

The study will be conducted at the Unità Complessa di Odontoiatria, Azienda Unità Sanitaria Locale (A.U.S.L.) of Ferrara (Director: Prof. Leonardo Trombelli), in collaboration with nine (9) other Italian clinical centers.

Read the detailed description

The present multicenter cross-sectional clinical study aims at validateing the Italian version of one of the most widely used epidemiological questionnaires for periodontitis screening: the CDC/AAP questionnaire [hereafter referred to as CDC/AAP_ITA]. Furthermore, the study aims at developing a modified version of the CDC/AAP_ITA questionnaire, enriched with additional questions, and to assess its diagnostic accuracy [hereafter referred to as QSIdP].

All procedures included in the study protocol will be conducted in full compliance with the latest version of the Declaration of Helsinki. Participation in the study will require the signing of an informed consent form by each enrolled participant. In addition, the study will adhere to the STARD (Standards for Reporting Diagnostic Accuracy) guidelines.

Following development and validation, the CDC/AAP_ITA questionnaire (consisting of 8 questions) and the QSIdP questionnaire (consisting of 10 questions) will be administered to 495 patients with heterogeneous periodontal conditions recruited from ten Italian university clinical centers and/or public health facilities. Among these, Unità Complessa di Odontoiatria, Azienda Unità Sanitaria Locale (A.U.S.L.) of Ferrara (Director: Prof. Leonardo Trombelli), will be the Coordinating Center.

Within each center, patients will be enrolled according to specific inclusion criteria (i.e., age ≥18 years, ability to read and understand Italian, willingness to participate in the study) and exclusion criteria (i.e., completely edentulous individuals, subjects who have taken antibiotics within the past 3 months, pregnant women, or individuals with contraindications to periodontal probing).

Patient selection will take place during their stay in the waiting area of each participating clinical center, regardless of their chief complaint. Therefore, the questionnaires will be administered to all first-visit patients (and not exclusively to those seeking periodontal assessment).

Participants enrolled in the study will be asked to complete both the CDC/AAP_ITA and QSIdP questionnaires without external assistance. Each questionnaire will be identified by an alphanumeric code composed of the center's identifier and a progressive number. Only the principal investigator at each clinical center will hold the list linking patient names to their corresponding alphanumeric codes, thereby ensuring complete data de-identification.

Upon completion of the CDC/AAP_ITA and QSIdP questionnaires, participants will undergo a full-mouth periodontal clinical examination aimed at recording the following clinical parameters: probing depth (PD), clinical attachment level (CAL), and bleeding on probing (BoP%). Demographic information (age, sex, body mass index), medical history (diabetes, other systemic diseases), and smoking habits will be retrieved from the patient's clinical record. In cases where this information is missing or outdated (more than six months), it will be reconfirmed with the patient. When available, radiographic information will also be integrated into the clinical data.

The clinician responsible for recording clinical parameters will then formulate a periodontal diagnosis according to two different classification systems:

i) Page \& Eke, the reference standard for epidemiological studies; and ii) Tonetti et al. case definition for periodontitis.

The association between self-reported measures of periodontal disease (derived from the questionnaires) and clinical diagnosis (derived from the periodontal examination) will be analyzed using logistic regression models adjusted for potential patient-specific confounders.

02

Conditions studied

  • Periodontal Diseases
  • Periodontitis

Keywords

  • diagnosis
  • self-reported questionnaire
  • validation
  • sensitivity
  • specificity
03

In context

Periodontal Diseases

830 studies on the registry are indexed under Periodontal Diseases; 188 are open to participants now.

This study's planned enrollment of 495 is above the median of 100 across 291 observational studies indexed under Periodontal Diseases.

Browse Periodontal Diseases studies →

Lead sponsor

Azienda Unità Sanitaria Locale (A.U.S.L.) Ferrara, Italy is the lead sponsor of 2 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Patients waiting in the waiting area of the participating clinical centers without a specific chief complaint.

Inclusion criteria

  • age ≥18 years;
  • ability to read and understand Italian;
  • willingness to participate in the study

Exclusion criteria

Exclusion Criteria:

  • completely edentulous individuals;
  • subjects who have taken antibiotics within the past 3 months;
  • pregnant women;
  • individuals with contraindications to periodontal probing
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
495 participants (estimated)
Patient registry
No

Groups and cohorts

  • Patients receiving "CDC/AAP_ITA" and "QSIdP" questionnaire

    Patients enrolled in the study (and belonging the unique examined study group) will receive the "CDC/AAP\_ITA" and "QSIdP" questionnaires while waiting in the waiting room of one of the Clinical Centers. They will be instructed to complete the questionnaires independently and without assistance.

06

What researchers measure

Primary outcomes

  1. Specificity

    questionnaire ability to correctly reject healthy patients without a condition

    Time frame: baseline visit

  2. sensitivity

    questionnaire ability to correctly detect ill patients out of those who do have the condition

    Time frame: baseline vist

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Montero E, La Rosa M, Montanya E, Calle-Pascual AL, Genco RJ, Sanz M, Herrera D. Validation of self-reported measures of periodontitis in a Spanish Population. J Periodontal Res. 2020 Jun;55(3):400-409. doi: 10.1111/jre.12724. Epub 2019 Dec 24. PubMed 31872881 ↗
  • Carra MC, Gueguen A, Thomas F, Pannier B, Caligiuri G, Steg PG, Zins M, Bouchard P. Self-report assessment of severe periodontitis: Periodontal screening score development. J Clin Periodontol. 2018 Jul;45(7):818-831. doi: 10.1111/jcpe.12899. Epub 2018 May 16. PubMed 29611224 ↗
  • Deng K, Pelekos G, Jin L, Tonetti MS. Diagnostic accuracy of self-reported measures of periodontal disease: A clinical validation study using the 2017 case definitions. J Clin Periodontol. 2021 Aug;48(8):1037-1050. doi: 10.1111/jcpe.13484. Epub 2021 Jun 1. PubMed 33998009 ↗
  • Tonetti MS, Greenwell H, Kornman KS. Staging and grading of periodontitis: Framework and proposal of a new classification and case definition. J Clin Periodontol. 2018 Jun;45 Suppl 20:S149-S161. doi: 10.1111/jcpe.12945. PubMed 29926495 ↗
  • Eke PI, Genco RJ. CDC Periodontal Disease Surveillance Project: background, objectives, and progress report. J Periodontol. 2007 Jul;78(7 Suppl):1366-71. doi: 10.1902/jop.2007.070134. PubMed 17610396 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 10, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07461753
Lead sponsor
Azienda Unità Sanitaria Locale (A.U.S.L.) Ferrara, Italy
Responsible party
Prof. Leonardo Trombelli (full professor, Azienda Unità Sanitaria Locale (A.U.S.L.) Ferrara, Italy) — Principal investigator
First posted
Mar 10, 2026
Start date
Apr 2026 (estimated)
Primary completion
Sep 2026 (estimated)
Completion
Jan 2027 (estimated)
Last update
Mar 10, 2026

Study contacts

Leonardo Trombelli, principal investigator
Contact
leonardo.trombelli@unife.it
+39 0532 688506
Anna Simonelli
Contact
anna.simonelli@unife.it
0532 688506

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion